Search research articles
Contact Us
Filters
Showing results (151-160 of 425) with videos related to
Page
of 43
Sort By:
Current Atherosclerosis Reports
|
March 13, 2014
HDL hypothesis: where do we stand now?
Sayed M Tariq, Mandeep S Sidhu, Peter P Toth, et al.
Nutrients
|
May 27, 2023
Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review
Arrigo F G Cicero, Federica Fogacci, Anca Pantea Stoian, et al.
Journal of Clinical Lipidology
|
December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease
Peter P Toth, George Thanassoulis, Ken Williams, et al.
Archives of Medical Science : AMS
|
June 10, 2016
Molecular mechanisms of statin intolerance
Anna Gluba-Brzozka, Beata Franczyk, Peter P Toth, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
Estimated ASCVD risk according to statin use in US adults with borderline triglycerides: Results from National Health and Nutrition Examination Survey (NHANES) 2007-2014
Wenjun Fan, Sephy Philip, Peter P Toth, et al.
Journal of Clinical Lipidology
|
June 16, 2015
Is HPS2-THRIVE the death knell for niacin?
Peter P Toth, Avinash M Murthy, Mandeep S Sidhu, et al.
Cardiology and Therapy
|
April 25, 2020
Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007-2014
Wenjun Fan, Sephy Philip, Craig Granowitz, et al.
Journal of Clinical Lipidology
|
December 31, 2018
Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey
Wenjun Fan, Sephy Philip, Craig Granowitz, et al.
Journal of Clinical Lipidology
|
August 12, 2014
JCL roundtable: HDL in the primary care setting
W Virgil Brown, Benjamin J Ansell, Rachel H Mackey, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Differentiating EPA from EPA/DHA in cardiovascular risk reduction
Peter P Toth, M John Chapman, Klaus G Parhofer, et al.
Page
of 43
Search research articles
Search
Showing results (151-160 of 425) with videos related to
Sort By:
Page
of 43
Current Atherosclerosis Reports
|
March 13, 2014
HDL hypothesis: where do we stand now?
Sayed M Tariq, Mandeep S Sidhu, Peter P Toth, et al.
Nutrients
|
May 27, 2023
Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review
Arrigo F G Cicero, Federica Fogacci, Anca Pantea Stoian, et al.
Journal of Clinical Lipidology
|
December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease
Peter P Toth, George Thanassoulis, Ken Williams, et al.
Archives of Medical Science : AMS
|
June 10, 2016
Molecular mechanisms of statin intolerance
Anna Gluba-Brzozka, Beata Franczyk, Peter P Toth, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
Estimated ASCVD risk according to statin use in US adults with borderline triglycerides: Results from National Health and Nutrition Examination Survey (NHANES) 2007-2014
Wenjun Fan, Sephy Philip, Peter P Toth, et al.
Journal of Clinical Lipidology
|
June 16, 2015
Is HPS2-THRIVE the death knell for niacin?
Peter P Toth, Avinash M Murthy, Mandeep S Sidhu, et al.
Cardiology and Therapy
|
April 25, 2020
Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007-2014
Wenjun Fan, Sephy Philip, Craig Granowitz, et al.
Journal of Clinical Lipidology
|
December 31, 2018
Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey
Wenjun Fan, Sephy Philip, Craig Granowitz, et al.
Journal of Clinical Lipidology
|
August 12, 2014
JCL roundtable: HDL in the primary care setting
W Virgil Brown, Benjamin J Ansell, Rachel H Mackey, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Differentiating EPA from EPA/DHA in cardiovascular risk reduction
Peter P Toth, M John Chapman, Klaus G Parhofer, et al.
Page
of 43